Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Apogenix

    Client Virtual Booth

    APOGENIX

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Apogenix
    Germany Flag
    Country
    Country
    Germany
    Address
    Address
    Im Neuenheimer Feld 584, 69120 Heidelberg,
    Telephone
    Telephone
    +49 6221 58608-0
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://apogenix.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/apogenix-gmbh/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Apogenix’s asunercept demonstrates efficacy in COVID-19 trial
    Apogenix’s asunercept demonstrates efficacy in COVID-19 trial

    https://www.pharmatimes.com/news/apogenixs_asunercept_demonstrates_efficacy_in_covid-19_trial_1456969

    PHARMATIMES
    19 Oct 2022
    Share Share
    Apogenix Receives €20.7 M in Public Funding for Pivotal Study and Preparation
    Apogenix Receives €20.7 M in Public Funding for Pivotal Study and Preparation

    https://uk.finance.yahoo.com/news/apogenix-receives-eur-20-7-090007056.html

    YAHOO
    09 Dec 2021
    Share Share
    Phase II trial to treat COVID-19 initiated in Vienna as an academia-industry
    Phase II trial to treat COVID-19 initiated in Vienna as an academia-industry

    http://www.pharmabiz.com/NewsDetails.aspx?aid=134352&sid=2

    PHARMABIZ
    23 Dec 2020
    Share Share
    Phase II trial to treat COVID-19 initiated in Vienna as an academia-industry
    Phase II trial to treat COVID-19 initiated in Vienna as an academia-industry

    http://www.pharmabiz.com/NewsDetails.aspx?aid=134352&sid=2

    PHARMABIZ
    23 Dec 2020
    Share Share
    Apogenix Advances Clinical Development of CD95L Inhibitor Asunercept
    Apogenix Advances Clinical Development of CD95L Inhibitor Asunercept

    https://uk.finance.yahoo.com/news/apogenix-advances-clinical-development-cd95l-080002143.html

    YAHOO
    13 Oct 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search